Elevation Oncology Inc is an oncology company focused on the development of selective cancer therapies to treat patients across a range of solid tumors with unmet medical needs... Show more
The Moving Average Convergence Divergence (MACD) for ELEV turned positive on August 21, 2025. Looking at past instances where ELEV's MACD turned positive, the stock continued to rise in of 31 cases over the following month. The odds of a continued upward trend are .
The Aroon Indicator for ELEV entered a downward trend on August 25, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Industry Biotechnology